GNC Holdings has canceled a bankruptcy auction after no new suitors emerged and will instead proceed with a sale to China-based Harbin Pharmaceutical Group, which already owns a stake of around 40% in the vitamin retailer. Sen. Marco Rubio, R.-Fla., has raised concerns about the deal, saying it could give the Chinese government access to health data on US consumers.
Chinese pharmaceutical company to acquire GNC
Sign up for NRF SmartBrief
News about the U.S. retail industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.